Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis

Дата публикации: 08-04-2026 16:49:18

Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas.Continue reading

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Why Biogen Is Paying $5.6B to Buy Apellis Pharma	0	5	03-04-2026
2	Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma	0	5	09-03-2026
3	Neurocrine’s $2.9B Soleno Buyout Brings What Could Become Its Next Blockbuster Drug	5	7	07-04-2026
4	United Therapeutics Buys Thymmune For Up To $300M	0	5	02-07-2026
5	Novartis is buying a U.K. cancer drug startup for up to $1.5 billion	0	7	06-07-2026
6	Anduril Raises $5 Billion In New Round; Company Valuation At $61 Billion	0	7	13-05-2026
7	Why UHS Is Acquiring Talkspace for $835M	0	5	11-03-2026
8	Gilat to Acquire Comtech’s Satellite and Space Business, Targeting US Defense Growth	0	5	16-06-2026
9	Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum And Strong Product-Level Performance Of GRAFAPEX (Treosulfan) For Injection	5	5	25-06-2026
10	2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal	0	7	25-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: dealbreaker.com.